John Cini
Gründer bei SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Vermögen: 3 221 $ am 30.04.2024
Aktive Positionen von John Cini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - |
| Gründer | 01.01.2011 | - | |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | - |
| Gründer | 01.01.2015 | - |
Karriereverlauf von John Cini
Ehemalige bekannte Positionen von John Cini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2011 | 01.04.2015 |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von John Cini
| University of North Texas | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
| OUTLOOK THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
